A major breakthrough in cancer investigation is occurring with the use of mini-antibodies to reactivate mutated p53. This crucial tumor inhibitor protein is frequently disabled in various forms of cancer, leading https://bookmarkinglog.com/story21983583/mini-antibodies-revive-p53-a-new-pathway-for-malignant-treatment